5-(di-tert-Butylphosphino)-1',3',5'-triphenyl-1'H-1,4'-bipyrazole

Catalog No. :
ACOVWB326
CAS No. :
894086-00-1
Molecular Formula :
C32H35N4P
Molecular Weight :
506.63

IUPAC Name:5-(di-tert-butylphosphaneyl)-1',3',5'-triphenyl-1'H-1,4'-bipyrazole

5-(di-tert-Butylphosphino)-1',3',5'-triphenyl-1'H-1,4'-bipyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$87.00Login to see priceIn stockInquiry
100g98%$318.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(di-tert-Butylphosphino)-1',3',5'-triphenyl-1'H-1,4'-bipyrazole
IUPAC Name5-(di-tert-butylphosphaneyl)-1',3',5'-triphenyl-1'H-1,4'-bipyrazole
MDL No.MFCD09038440
Molecular FormulaC32H35N4P
Molecular Weight506.63
SMILESCC(P(C1=CC=NN1C2=C(C3=CC=CC=C3)N(C4=CC=CC=C4)N=C2C5=CC=CC=C5)C(C)(C)C)(C)C
InChI KeyPTXJGGGNGMPMBG-UHFFFAOYSA-N
Synonym5-(DI-T-BUTYLPHOSPHINO)-1',3',5'-TRIPHENYL-1,4'-BI-1H-PYRAZOLE | 5-(di-tert-butylphosphanyl)-1',3',5'-triphenyl-1'H-1,4'-bipyrazole | 5-(DI-T-BUTYLPHOSPHINO)-1',3',5'-TRIPHENYL-1,4'-BI-1H-PYRAZOLE;5-(DI-TERT-BUTYLPHOSPHINO)-1',3',5'-TRIPHENYL-1'H-1,4-BIPY
CAS No.894086-00-1
PubChem CID11547931

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOVWB326 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOVWB326 route product structure diagram
    ACOVWB326894086-00-1 In Stock
Inquiry

2. ACOVWB326 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOVWB326 route product structure diagram
    ACOVWB326894086-00-1 In Stock
Inquiry

Comments (0)